May 11, 2020 / 12:35 PM / 14 days ago

BRIEF-Intercept Pharma Reports First Quarter 2020 Financial Results

May 11 (Reuters) - Intercept Pharmaceuticals Inc:

* INTERCEPT PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS, AND PROVIDES BUSINESS UPDATE

* Q1 REVENUE $72.7 MILLION VERSUS REFINITIV IBES ESTIMATE OF $69.7 MILLION

* IN Q1 OF 2020 WE REPORTED A NET LOSS OF $93.0 MILLION, AN INCREASE COMPARED TO A NET LOSS OF $90.3 MILLION IN Q1 2019

* ARE NOT PROVIDING FULL YEAR 2020 NET SALES GUIDANCE

* CONTINUE TO EXPECT NON-GAAP ADJUSTED OPERATING EXPENSES FOR 2020 TO BE IN RANGE OF $560 MILLION TO $600 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below